We're a non-profit dedicated to making medications affordable for everyone in America. Follow us here for advice on how to deal with health insurance companies.
Nearly a million Americans are living with multiple sclerosis.
Meet some of the biotech innovators racing to develop breakthrough treatments for patients and their families still waiting for a cure.
Together, we can create a future without MS.
Massachusetts students: the stories behind medical innovation deserve to be told, and we want to fund yours.
The MA Innovation Storytelling Challenge is open to students and recent graduates. Film it, write it, code it. Win up to $2,000.
Deadline 6/12: https://t.co/AuwRBkfbvA
Missed our recent webinar? Or tuned in and want to learn more?
Watch the full recording and explore our resource hub—with key information, tools, and actions.
Check it out here: https://t.co/iv1DjAbRwE
Join our free and fully virtual biotech fellowship for students and professionals this summer:
1. Learn more: 1-min video https://t.co/yUq92paxE8
2. Complete course 6-10 hrs course pre-req. https://t.co/2Ag9ZgHFMu
3. Apply by June 10: https://t.co/Cj1nCPai68
#Biotech #Fellowship #NPLB
Curious about how we can go back on the offensive when it comes to maintaining America’s leadership in biopharma innovation?
Check out this op-ed from NPLB Board Member @davidbeier1747 of @baycitycapital.
Playing defense is a losing strategy: The U.S. needs an offensive biopharma plan, writes David Beier in a BioCentury Guest Commentary. The U.S. still leads in biopharma innovation. Defensive policy alone will lose it https://t.co/ghwgu3aqEq
When Katherine Sneddon, a patient with cystic fibrosis, had a lapse in insurance coverage, she turned to her med's inventor for help.
Thanks to NPLB Biotech Fellow Pratham Modi, find programs with our new tool: https://t.co/gBrIcbVWmz
#CFAwarenessMonth#CallTheInventors
Mental health is seeing real progress, yet coverage barriers prevent patients from getting new treatments.
Join us 5/28 for our free webinar unpacking the gap between progress and access, and what advocates can do.
Register: https://t.co/h550NdVtM7
Mental health innovation is moving faster than the system that supports it. The window to fix insurance is right now.
Join us May 28th at 11:00am EST to learn more about what's at stake—and what you can do about it.
Register: https://t.co/BbKcRRrTs0
On #WorldSchizophreniaDay, we’re highlighting a key reality: mental health innovation is advancing rapidly, but patients are struggling to access it.
Join our webinar, Mind the Gap: Mental Health Innovation vs. Real-World Access, on 5/28.
Register: https://t.co/3a7sJanRV2
At #ISPOR2026, NPLB advisor @Richard_Z_Xie joined leaders across HEOR and biotech investing to discuss how we can better define the real-world value of innovative medicines and support patients.
Explore the value of medicines: https://t.co/eYSkPZtoj6
At America Innovates, Stand Up for Science asked: What do people want from U.S. innovation? Answers ranged from cures for ALS to tastier meds.
The breakthroughs we all rely on only happen if we #ProtectInnovation, from the NIH to biopharma.
Thank you to SUFS for hosting!
Delays. Denials. Dead ends.
Innovation in mental healthcare is accelerating. So why are patients still not getting what they need? We're breaking it all down on May 28th.
Register for free: https://t.co/IBSf5eQZW4
Join NPLB at America Innovates, May 16-18 in SF, a free event, open to the public.
Look for us at the Stand Up for Science booth.
📌 Register: https://t.co/x5TbnJXZM6
The FDA will have a new leader at a pivotal moment for US biomedical innovation. We’re joining a coalition of leaders to support Dr. Richard Pazdur for the role.
FDA needs a leader with scientific credibility, consistency + proven leadership.
Sign: https://t.co/x2TLx6CvHB
Mental health is seeing real progress, yet coverage barriers prevent patients from getting new treatments.
Join us 5/28 for our free webinar unpacking the gap between progress and access, and what advocates can do.
Register: https://t.co/h550NdVtM7
On #WorldLupusDay, we’re highlighting @marisazeppieri. After waiting 15 yrs for a diagnosis, she now reaches millions through Lupus Chick.
We stand w/ patients + innovators developing new treatments.
🎥 https://t.co/hPQo32xMb3
+ Check our her new book: https://t.co/iq8F6jhLOj
No Patient Left Behind executive director Priscilla VanderVeer on the search for solutions to reduce drug prices:
"I think when we talk about solutions like MFN, like the Inflation Reduction Act ... we're looking at a solution that may not solve the problem." #AxiosLive
Can the GCEA calculator help innovators dream a little bigger?
NPLB Fellowship hosted Laura Tadvalkar and Richard Xie for a live session on applying GCEA to articulate the value of Cidara’s flu drug.
https://t.co/odn8BmNkjM
#NPLBFellowship#HealthEconomics#Biotech
Every blockbuster has an expiration date. How early should innovators start building what comes next?
Thank you to Fiona Mack (J&J) for sharing your expertise with our NPLB fellows last week!
Join us: https://t.co/odn8BmNkjM
#NPLBBiotechFellowship#Biotech
Autoimmune diseases affect 45M+ Americans.
This #AutoimmuneAwarenessMonth, we recognize everyone working to improve the lives of people impacted by autoimmune disease.
Progress is collective and personal.
📽️ Watch below:
Autoimmune diseases afflict 45 million Americans—and it requires a collective community effort to change that.
@NPLB_org's Community Quest video shows how investors, innovators, regulators, patients, insurers—and you—make new treatments possible, accessible, and affordable.